Becton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
